Population Pharmacokinetic/Pharmacodynamic Modeling of Sunitinib by Dosing Schedule in Patients with Advanced Renal Cell Carcinoma or Gastrointestinal Stromal Tumor.
Pharmacokinetic/pharmacodynamic modeling of sunitinib by dosage schedule in patients with advanced renal cell carcinoma or gastrointestinal stromal tumor.